Reflecting ongoing concerns around drug quality in India's pharmaceutical supply chain, the Central Drugs Standard Control ...

Mumbai, June 26 -- Prucalopride Tablets are the bioequivalent of Motegrity(R) Tablets, developed by Takeda Pharmaceuticals U.S.A., Inc. The medication is indicated for the treatment of chronic ...